National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 7) (PB 60 of 2019) (Cth)

Case

PB 60 of 2019

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 7)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated  26 July 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

  1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 7).

(2)This Instrument may also be cited as PB 60 of 2019.

  1. Commencement

This Instrument commences on 1 August 2019.

  1. Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

  1. Schedule 1, entry for Calcium

omit:

Tablet, chewable, 500 mg (as carbonate) 20 240 1
  1. Schedule 1, after entry for Flutamide

insert:

Fluticasone furoate Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses 20 1 5
Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses 20 1 5
  1. Schedule 1, after entry for Testosterone in the form Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2

insert:

Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses 20 1 5
  1. Schedule 1, after entry for Tiotropium with olodaterol

insert:

Tocilizumab Injection 162 mg in 0.9 mL single use pre-filled pen 20 4 5
20 4 6
Injection 162 mg in 0.9 mL single use pre-filled syringe 20 4 5
20 4 6
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0